• Policy
• Lucentis biosimilars have been applied to the MFDS
• by Lee, Tak-Sun Sep 1, 2021 05:57am

• Policy
• DREC to include patient and civic groups' recommendations
• by Lee, Hye-Kyung Sep 1, 2021 05:57am

• Policy
• MFDS requests supplements for porcine islet transplant trial
• by Lee, Tak-Sun Aug 31, 2021 06:14am

• Policy
• There is a need to apply the HPV vaccine NIP Men Under 17
• by Lee, Jeong-Hwan Aug 31, 2021 06:13am

• Policy
• Korean pharmas are pursuing various SGLT-2 combos
• by Lee, Tak-Sun Aug 30, 2021 05:55am

• Policy
• The patent for Breast Cancer Therapy Affinitor has been clos
• by Lee, Tak-Sun Aug 30, 2021 05:55am

• Policy
• Regulation of COVID-19 vaccines is imminent
• by Lee, Jeong-Hwan Aug 27, 2021 05:59am

• Policy
• RSA refund should be differentiated by income
• by Kim, Jung-Ju Aug 27, 2021 05:59am

• Policy
• Clinical trials of Jardiance have been approved
• by Lee, Tak-Sun Aug 26, 2021 05:58am

• Policy
• Ppl willing to pay max ₩13.52 mil. for one-shot therap
• by Kim, Jung-Ju Aug 26, 2021 05:58am